Get the Stockscreener App
4.15
1.19%
-0.05
After Hours:
4.15
Omeros Corporation stock is traded at $4.15, with a volume of 562.99K.
It is down -1.19% in the last 24 hours and down -0.72% over the past month.
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
See More
Previous Close:
$4.20
Open:
$4.19
24h Volume:
562.99K
Relative Volume:
0.52
Market Cap:
$282.43M
Revenue:
-
Net Income/Loss:
$-117.81M
P/E Ratio:
-2.2074
EPS:
-1.88
Net Cash Flow:
$74.30M
1W Performance:
-0.48%
1M Performance:
-0.72%
6M Performance:
-48.19%
1Y Performance:
+10.96%
1-Day Range:
$4.12
$4.19
1-Week Range:
$4.12
$4.34
52-Week Range:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Name
Omeros Corporation
Sector
Industry
Phone
206-676-5000
Address
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Compare OMER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
4.15 | 290.60M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-25 | Initiated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | D. Boral Capital | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Dec-08-22 | Downgrade | UBS | Buy → Neutral |
| Nov-08-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-08-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-08-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-21 | Downgrade | Maxim Group | Buy → Hold |
| Oct-01-21 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-27-21 | Initiated | JP Morgan | Neutral |
| Feb-01-21 | Initiated | UBS | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Aug-21-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-14-20 | Reiterated | Maxim Group | Buy |
| May-06-19 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-12-18 | Initiated | Seaport Global Securities | Buy |
| Mar-23-18 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-05-18 | Downgrade | Needham | Buy → Hold |
| Nov-08-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| Mar-17-17 | Reiterated | Maxim Group | Buy |
| Mar-17-17 | Reiterated | Needham | Buy |
| Nov-16-16 | Reiterated | Wedbush | Outperform |
| Nov-10-16 | Reiterated | Needham | Buy |
| Aug-10-16 | Reiterated | Maxim Group | Buy |
| Jun-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-02-16 | Reiterated | Needham | Buy |
| Feb-29-16 | Reiterated | Wedbush | Outperform |
| Nov-11-15 | Reiterated | Needham | Buy |
| Aug-18-15 | Reiterated | WBB Securities | Strong Buy |
| Aug-10-15 | Initiated | ROTH Capital | Buy |
View All
Omeros Corporation Stock (OMER) Latest News
Ancora Advisors LLC Sells 80,000 Shares of Omeros Corporation $OMER - MarketBeat
Omeros (NASDAQ:OMER) Earns Buy Rating from D. Boral Capital - MarketBeat
Will Omeros Corporation benefit from rising consumer demandPortfolio Update Summary & Precise Buy Zone Tips - beatles.ru
Will Omeros Corporation stock go up in YEARWeekly Earnings Recap & Long-Term Growth Portfolio Plans - beatles.ru
Nomura Holdings Inc. Cuts Stock Position in Omeros Corporation $OMER - MarketBeat
Can Omeros Corporation outperform in the next rallyQuarterly Investment Review & Expert-Curated Trade Recommendations - خودرو بانک
114,057 Shares in Omeros Corporation $OMER Purchased by Nuveen LLC - MarketBeat
Will Omeros Corporation benefit from AI trends2025 Dividend Review & Free Low Drawdown Momentum Trade Ideas - 더경남뉴스
Custom watchlist performance reports with Omeros CorporationRate Hike & Low Risk Investment Opportunities - Newser
Sector ETF performance correlation with Omeros CorporationJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
Published on: 2025-09-05 14:03:33 - Newser
Heatmap analysis for Omeros Corporation and competitorsJuly 2025 Trends & Long-Term Capital Growth Strategies - Newser
Strategies to average down on Omeros CorporationWeekly Earnings Recap & Expert Approved Trade Ideas - Newser
Is Omeros Corporation stock ready for a breakoutOil Prices & Low Drawdown Investment Strategies - Newser
Is Omeros Corporation stock entering bullish territory2025 Market Overview & Weekly High Potential Stock Alerts - Newser
136,002 Shares in Omeros Corporation $OMER Acquired by Wellington Management Group LLP - MarketBeat
What’s next for Omeros Corporation stock priceEarnings Trend Report & Growth Focused Stock Reports - Newser
What Fibonacci levels say about Omeros Corporation reboundPortfolio Return Report & Weekly Breakout Stock Alerts - Newser
Omeros Corporation’s volatility index tracking explainedMarket Risk Summary & Long-Term Capital Growth Ideas - Newser
What is Omeros Corporation’s valuation compared to sectorJuly 2025 Recap & AI Optimized Trade Strategies - خودرو بانک
Is Omeros Corporation forming a bottoming baseJuly 2025 Highlights & High Accuracy Investment Entry Signals - Newser
Signal strength of Omeros Corporation stock in tech scannersPortfolio Performance Report & Daily Volume Surge Trade Alerts - Newser
What’s next for Omeros Corporation stockWeekly Trade Report & AI Forecasted Entry/Exit Points - خودرو بانک
Is Omeros Corporation stock bottoming outJuly 2025 Summary & Daily Technical Forecast Reports - Newser
Omeros Corporation (NASDAQ:OMER) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Has Omeros Corporation found a price floorMarket Activity Summary & Daily Entry Point Trade Alerts - Newser
Should you wait for a breakout in Omeros CorporationMarket Growth Summary & Short-Term Trading Opportunity Alerts - Newser
Predicting Omeros Corporation trend using moving averagesMarket Risk Analysis & AI Driven Price Predictions - Newser
Combining machine learning predictions for Omeros CorporationWeekly Profit Summary & Long Hold Capital Preservation Tips - Newser
Will Omeros Corporation rebound enough to break evenBear Alert & AI Enhanced Trade Execution Alerts - Newser
What are Omeros Corporation’s recent SEC filings showingJuly 2025 Volume & Technical Pattern Based Signals - خودرو بانک
What momentum shifts mean for Omeros CorporationPortfolio Update Summary & Consistent Profit Trading Strategies - Newser
Advanced analytics toolkit walkthrough for Omeros Corporation2025 Market Outlook & Growth Focused Investment Plans - Newser
Omeros Corporation stock prediction for this week2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Is Omeros Corporation trending in predictive chart modelsPortfolio Performance Summary & Community Trade Idea Sharing - Newser
What makes Omeros Corporation stock attractive todayJuly 2025 Sector Moves & Free Accurate Trade Setup Notifications - خودرو بانک
Momentum divergence signals in Omeros Corporation chartJuly 2025 WrapUp & AI Powered Buy/Sell Recommendations - Newser
Is Omeros Corporation showing signs of accumulation2025 Earnings Impact & Weekly High Momentum Picks - Newser
Omeros Corporation stock retracement – recovery analysisJuly 2025 Final Week & Real-Time Volume Spike Alerts - Newser
How institutional ownership impacts Omeros Corporation stock2025 Risk Factors & Technical Buy Zone Confirmations - Newser
What to do if you’re stuck in Omeros Corporation2025 Performance Recap & Community Trade Idea Sharing - Newser
Movement Recap: Can Omeros Corporation deliver alphaQuarterly Profit Review & Verified Short-Term Plans - خودرو بانک
Omeros Corporation Stock (OMER) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):